Get the tools and support you need to best manage your eczema

  • This field is for validation purposes and should be left unchanged.

News

January 17, 2017 — Biologic drugs have been making headlines as potentially promising new therapies for treating atopic dermatitis (AD). Several have shown positive results in clinical trials and one, dupilumab, is being reviewed for approval by the Food and Drug Administration (FDA) and is expected to come to market in 2017. Biologic medications are […]

Read More


January 17, 2017 — For the first time, ever, the Institute for Clinical and Economic Review (ICER) has begun a process to review the clinical effectiveness and value of two new treatments for atopic dermatitis (AD). ICER is an independent, nonprofit organization that evaluates treatments for serious diseases such as cancer, multiple sclerosis and psoriasis, […]

Read More


January 9. 2017 — Last week, a panel of experts sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) released new guidelines for reducing the risk of peanut allergies in children. This panel, which included National Eczema Association, recommended giving children 6 months and younger peanut-containing foods under the direction of a pediatrician or […]

Read More


By Christopher Logas and Peter A. Lio, MD We share a lot with our beloved canines: our home, our bed and sometimes, even our dinner. But did you know that humans share something else with dogs? A diagnosis of atopic dermatitis (AD). Dogs with canine atopic dermatitis (CAD) have many of the same symptoms as […]

Read More


What is atopic dermatitis (AD)? AD is a severe form of eczema, which is an umbrella term used to describe a group of conditions that result in itchy, red, and irritated skin. It is a chronic, inflammatory disease that results in red, itchy patches on the skin that can crack and weep. AD falls into […]

Read More


The HBO mini-series called “The Night Of” is about a complicated murder case set in New York City. It’s about the transformation of a young Pakistani-American man from a “nice guy” to a Riker’s Island criminal. It’s also about eczema. And how this condition can affect every part of a person’s life. Actor John Turturro […]

Read More


By Jennifer Moyer Darr, LCSW, National Jewish Health in Denver, Colorado Children as young as three-years-old begin to notice differences about others (Chernyshov, 2016) and react to these differences. Sometimes, they are just curious and no harm is intended. Sometimes bullying follows. Bullying can occur in the form of verbal, physical, social or psychological taunts […]

Read More


December 20, 2016 — On December 14, the U.S. Food and Drug Administration approved Eucrisa (crisaborole), a topical treatment for children and adults with mild to moderate atopic dermatitis (AD). This marks the first new FDA-approved medication for atopic dermatitis in more than 10 years. “It’s a big deal because for at least 15 years, […]

Read More


December 20, 2016 — This year has been a busy one for eczema research. Currently, there are more than 40 therapies in development for eczema that have the potential to help symptoms such as itch and redness, improve the skin barrier and calm the immune system. Scientists are also looking at how eczema affects the […]

Read More


December 14, 2016 — People with atopic dermatitis have a new treatment option. Today, the U.S. Food and Drug Administration approved Eucrisa (crisaborole), a topical treatment for children and adults with mild to moderate atopic dermatitis (AD). Eucrisa works differently than other topical treatments on the market. It is not a steroid or a topical […]

Read More